Source disclosure: February 12, 2026
RIKEN VITAMIN CO.,LTD. [4526.T]
TOKYO, Feb 18 (Pulse News Wire) – Riken Vitamin Co., Ltd. (4526.T) reported consolidated results for Q3 FY2026 (ending March 2026).
5 billion (-0.5% YoY). 72 billion (-24.2%). net profit attributable to shareholders was ¥5.95 billion (+2.0%).
2%. For the next fiscal year, the company forecasts 0 billion (+0.4%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥72,503M | -0.5% |
| Operating profit | ¥5,716M | -24.2% |
| Net profit | ¥5,949M | +2.0% |
Next period forecast
Revenue
¥96,000M
+0.4%Op. profit
¥6,200M
-28.9%Net profit
¥6,500M
-30.8%Source: TDNet filing · Figures in millions of yen
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.